Our long term goal of this proposal is to elucidate the insulin function at molecular level using recently developed biochemical techniques such as microsequencing and molecular cloning. Recent rapid advances in genetic engineering technology have had a dramatic impact on biomedical research in many areas related to diabetes. These advances have resulted in providing potentially unlimited supplies of insulin and also chemical probes for the analysis of DNA and RNA structure and of gene function and expression which are useful for a better understanding of the production of insulin in Beta cells. The insulin receptor is thought to play an important role in insulin action. Abnormality in the receptor number and/or structure have been observed in some forms of diabetes. The insulin receptor is a large glycoprotein with Mr=300,000-350,000 which is composed of two Mr=125,000(Alpha) and two Mr=90,000(Beta) subunits and is only available in very small quantities. Thus, it has not been possible to purify enough amount of receptor protein to further characterize it. Therefore, application of newly developed genetic engineering technology to the studies on insulin receptor would be highly desirable since it could not only reveal the complete DNA and amino acid sequence of the receptor but also provide us new strategies for more detailed understanding of the mechanism of insulln action and cause of diabetes. 1) Our approach for determining the complete amino acid sequence of the receptor is, therefore, i) to determine the partial amino acid sequence of the purified insulin receptor, ii) to clone cDNA coded for the receptor using synthetic oligonucleotide probes whose sequence will be predicted from the partial amino acid sequence of the receptor and iii) to deduce the total amino acid sequence of the receptor from the DNA sequence of the cloned cDNA. 2) Once we isolate the clones carrying insulin receptor cDNA sequence, we would be able to study a variety of projects including structure and organization of insulin receptor gene, genetic basis of diabetes, and mechanism of insulin receptor-gene expression. Furthermore, it will be possible to mutate the receptor gene and examine the function of the receptor. These studies would reveal new sights towards understanding diabetes and eventually curing the disease or preventing its complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK029770-08
Application #
3229025
Study Section
Molecular Biology Study Section (MBY)
Project Start
1981-08-01
Project End
1990-07-31
Budget Start
1988-08-01
Budget End
1990-07-31
Support Year
8
Fiscal Year
1988
Total Cost
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
LeBon, T R; Kasuya, J; Paxton, R J et al. (1992) Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions. Endocrinology 130:3265-74
Fujita-Yamaguchi, Y; Harmon, J T; Kathuria, S (1989) Radiation inactivation experiments predict that a large aggregate form of the insulin receptor is a highly active tyrosine-specific protein kinase. Biochemistry 28:4556-63
Sacks, D B; McDonald, J M (1989) Calmodulin as substrate for insulin-receptor kinase. Phosphorylation by receptors from rat skeletal muscle. Diabetes 38:84-90
Fujita-Yamaguchi, Y; Kathuria, S; Xu, Q Y et al. (1989) In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate. Proc Natl Acad Sci U S A 86:7306-10
Sacks, D B; Fujita-Yamaguchi, Y; Gale, R D et al. (1989) Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta. Biochem J 263:803-12
Fujita-Yamaguchi, Y; Sacks, D B; McDonald, J M et al. (1989) Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine). Biochem J 263:813-22
Fujita-Yamaguchi, Y; Harmon, J T (1988) A monomer-dimer model explains the results of radiation inactivation: binding characteristics of insulin receptor purified from human placenta. Biochemistry 27:3252-60
Wang, C C; Goldfine, I D; Fujita-Yamaguchi, Y et al. (1988) Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor. Proc Natl Acad Sci U S A 85:8400-4
Sahal, D; Ramachandran, J; Fujita-Yamaguchi, Y (1988) Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates. Arch Biochem Biophys 260:416-26
Okamoto, M; Kahn, C R; Maron, R et al. (1988) Decreased autophosphorylation of EGF receptor in insulin-deficient diabetic rats. Am J Physiol 254:E429-34